Adult T-cell leukemia/lymphoma: complexities in diagnosis and novel treatment strategies. 2009

Jeffrey A Barnes, and Jeremy S Abramson
Center for Lymphoma, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA.

UI MeSH Term Description Entries
D008297 Male Males
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015459 Leukemia-Lymphoma, Adult T-Cell Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. ATLL,HTLV I Associated T Cell Leukemia Lymphoma,HTLV-Associated Leukemia-Lymphoma,HTLV-I-Associated T-Cell Leukemia-Lymphoma,Human T Lymphotropic Virus Associated Leukemia Lymphoma,Human T Lymphotropic Virus-Associated Leukemia-Lymphoma,Human T-Cell Leukemia-Lymphoma,Leukemia Lymphoma, Adult T Cell,Leukemia Lymphoma, T Cell, Acute, HTLV I Associated,Leukemia, Adult T-Cell,Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated,T Cell Leukemia Lymphoma, HTLV I Associated,T Cell Leukemia, Adult,T-Cell Leukemia, Adult,T-Cell Leukemia-Lymphoma, Adult,T-Cell Leukemia-Lymphoma, HTLV-I-Associated,Adult T-Cell Leukemia,Adult T-Cell Leukemia-Lymphoma,Adult T-Cell Leukemia-Lymphomas,Adult T-Cell Leukemias,HTLV Associated Leukemia Lymphoma,HTLV-Associated Leukemia-Lymphomas,HTLV-I-Associated T-Cell Leukemia-Lymphomas,Human T Cell Leukemia Lymphoma,Human T-Cell Leukemia-Lymphomas,Leukemia, Adult T Cell,Leukemia-Lymphoma, HTLV-Associated,Leukemia-Lymphoma, HTLV-I-Associated T-Cell,Leukemia-Lymphoma, Human T-Cell,Leukemia-Lymphomas, Adult T-Cell,Leukemia-Lymphomas, HTLV-Associated,Leukemia-Lymphomas, HTLV-I-Associated T-Cell,Leukemia-Lymphomas, Human T-Cell,Leukemias, Adult T-Cell,T Cell Leukemia Lymphoma, Adult,T-Cell Leukemia-Lymphoma, Human,T-Cell Leukemia-Lymphomas, Adult,T-Cell Leukemia-Lymphomas, HTLV-I-Associated,T-Cell Leukemia-Lymphomas, Human,T-Cell Leukemias, Adult
D015480 Deltaretrovirus Antibodies Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens. BLV Antibodies,HTLV Antibodies,HTLV-BLV Antibodies,Human T-Cell Leukemia Virus Antibodies,Leukemia Virus Antibodies, Human T-Cell,Leukemia-Lymphoma Virus Antibodies, Human T-Cell,T-Cell Leukemia-Lymphoma Virus Antibodies, Human,Human T Cell Leukemia Virus Antibodies,Leukemia Lymphoma Virus Antibodies, Human T Cell,Leukemia Virus Antibodies, Human T Cell,T Cell Leukemia Lymphoma Virus Antibodies, Human,Antibodies, BLV,Antibodies, Deltaretrovirus,Antibodies, HTLV,Antibodies, HTLV-BLV,HTLV BLV Antibodies

Related Publications

Jeffrey A Barnes, and Jeremy S Abramson
December 2010, Expert review of hematology,
Jeffrey A Barnes, and Jeremy S Abramson
April 2012, Nihon rinsho. Japanese journal of clinical medicine,
Jeffrey A Barnes, and Jeremy S Abramson
January 2020, Frontiers in microbiology,
Jeffrey A Barnes, and Jeremy S Abramson
June 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Jeffrey A Barnes, and Jeremy S Abramson
October 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Jeffrey A Barnes, and Jeremy S Abramson
May 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Jeffrey A Barnes, and Jeremy S Abramson
January 2007, Nihon rinsho. Japanese journal of clinical medicine,
Jeffrey A Barnes, and Jeremy S Abramson
April 2021, Seminars in hematology,
Jeffrey A Barnes, and Jeremy S Abramson
April 2023, International journal of hematology,
Jeffrey A Barnes, and Jeremy S Abramson
August 2017, Journal of oncology practice,
Copied contents to your clipboard!